The combination of urine DD3(PCA3) mRNA and PSA mRNA as molecular markers of prostate cancer (Q34984413)

5 August 2017

The combination of urine DD3(PCA3) mRNA and PSA mRNA as molecular markers of prostate cancer (English)

1 reference

5 August 2017

Ettore Mearini

1

1 reference

5 August 2017

Cinzia Antognelli

2

1 reference

5 August 2017

Chiara Del Buono

3

1 reference

5 August 2017

Giovanni Cochetti

4

1 reference

5 August 2017

Antonella Giannantoni

5

1 reference

5 August 2017

Emanuela Nardelli

6

1 reference

5 August 2017

Vincenzo N Talesa

7

1 reference

5 August 2017

1 June 2009

1 reference

5 August 2017

1 reference

5 August 2017

14

1 reference

5 August 2017

4

1 reference

5 August 2017

235-243

1 reference

The human plasma proteome: history, character, and diagnostic prospects

5 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

Prostate cancer diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

Housekeeping genes in cancer: normalization of array data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

The endothelial nitric oxide synthase Glu-298-Asp polymorphism and its mRNA expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

Prostate-specific antigen and androgen deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

New targets for therapy in prostate cancer: differential display code 3 (DD3PCA3), a highly prostate cancer–specific gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

Prostate-specific antigen expression is regulated by an upstream enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

Hormonal predictors of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

Circulating biomarkers for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

Molecular characterization of human prostate carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902807306

10.1080/13547500902807306

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference